These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31408901)

  • 1. Antagonizing P2Y12 Receptor Inhibitors: Current and Future Options.
    Trenk D; Hille L; Leggewie S; Stratz C; Nührenberg TG; Aradi D; Schrör K; Sibbing D
    Thromb Haemost; 2019 Oct; 119(10):1606-1616. PubMed ID: 31408901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of P2Y12 receptor antagonists on platelet function and clinical outcomes in patients undergoing Primary PCI: A substudy of the HEAT-PPCI trial.
    Shahzad A; Khanna V; Kemp I; Shaw M; Mars C; Cooper R; Wilson K; Curzen N; Stables RH
    EuroIntervention; 2018 Mar; 13(16):1931-1938. PubMed ID: 29336311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the pharmacological profiles of prasugrel and ticagrelor assessed by platelet aggregation, thrombus formation and haemostasis in rats.
    Sugidachi A; Ohno K; Ogawa T; Jakubowski J; Hashimoto M; Tomizawa A
    Br J Pharmacol; 2013 May; 169(1):82-9. PubMed ID: 23347039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of ex vivo autologous and in vivo platelet transfusion in the reversal of P2Y12 inhibition by clopidogrel, prasugrel, and ticagrelor: the APTITUDE study.
    O'Connor SA; Amour J; Mercadier A; Martin R; Kerneis M; Abtan J; Brugier D; Silvain J; Barthélémy O; Leprince P; Montalescot G; Collet JP;
    Circ Cardiovasc Interv; 2015 Nov; 8(11):e002786. PubMed ID: 26553698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell Surface Platelet Tissue Factor Expression: Regulation by P2Y
    Brambilla M; Becchetti A; Rovati GE; Cosentino N; Conti M; Canzano P; Giesen PLA; Loffreda A; Bonomi A; Cattaneo M; De Candia E; Podda GM; Trabattoni D; Werba PJ; Campodonico J; Pinna C; Marenzi G; Tremoli E; Camera M
    Arterioscler Thromb Vasc Biol; 2023 Oct; 43(10):2042-2057. PubMed ID: 37589138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized Comparison of Oral P2Y
    Hochholzer W; Kleiner P; Younas I; Valina CM; Löffelhardt N; Amann M; Bömicke T; Ferenc M; Hauschke D; Trenk D; Neumann FJ; Stratz C
    JACC Cardiovasc Interv; 2017 Jan; 10(2):121-129. PubMed ID: 28104204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of the platelet inhibitory effect of the P2Y
    Schoener L; Jellinghaus S; Richter B; Pfluecke C; Ende G; Christoph M; Quick S; Loehn T; Speiser U; Poitz DM; Mierke J; Strasser RH; Ibrahim K
    Clin Res Cardiol; 2017 Nov; 106(11):868-874. PubMed ID: 28653184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response variability to P2Y12 receptor inhibitors: expectations and reality.
    Siller-Matula JM; Trenk D; Schrör K; Gawaz M; Kristensen SD; Storey RF; Huber K;
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1111-28. PubMed ID: 24262612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic/pharmacodynamic modeling of drug interactions at the P2Y
    Henrich A; Claussen CH; Dingemanse J; Krause A
    CPT Pharmacometrics Syst Pharmacol; 2021 Jul; 10(7):735-747. PubMed ID: 33955698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registry.
    Olivier CB; Diehl P; Schnabel K; Weik P; Zhou Q; Bode C; Moser M
    Thromb Haemost; 2014 Feb; 111(2):266-72. PubMed ID: 24172891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical validation of AggreGuide A-100 ADP, a novel assay for assessing the antiplatelet effect of oral P2Y
    Gurbel PA; Tantry US; Bliden KP; Fisher R; Sukavaneshvar S; Dahlen J; Speros PC
    J Thromb Thrombolysis; 2021 Jul; 52(1):272-280. PubMed ID: 34143384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Pharmacodynamic Study of CN-218, a Novel Antiplatelet and Antithrombotic Agent Primarily Targeting the P2Y
    Li X; Liu P; Xu Z; Sun D; Gu J; Miao Y; Zhang J; Cao X
    Cardiovasc Drugs Ther; 2020 Feb; 34(1):15-23. PubMed ID: 32062793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet reactivity after administration of third generation P2Y12-antagonists does not depend on body weight in contrast to clopidogrel.
    Olivier CB; Schnabel K; Weber S; Zhou Q; Bode C; Moser M; Diehl P
    J Thromb Thrombolysis; 2016 Jul; 42(1):84-9. PubMed ID: 26837379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal strategy in antagonizing the P2Y12 -inhibitor ticagrelor.
    Hobl EL; Derhaschnig U; Firbas C; Schoergenhofer C; Schwameis M; Jilma B
    Eur J Clin Invest; 2013 Dec; 43(12):1258-61. PubMed ID: 24112116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet inhibition by P2Y
    Shih CC; Chan MV; Kirkby NS; Vojnovic I; Mitchell JA; Armstrong PC; Warner TD
    Br J Pharmacol; 2021 Dec; 178(23):4758-4771. PubMed ID: 34383973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SAR216471, an alternative to the use of currently available P2Y₁₂ receptor inhibitors?
    Delesque-Touchard N; Pflieger AM; Bonnet-Lignon S; Millet L; Salel V; Boldron C; Lassalle G; Herbert JM; Savi P; Bono F
    Thromb Res; 2014 Sep; 134(3):693-703. PubMed ID: 25064036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Function and Regulation of Platelet P2Y12 Receptor.
    Li X; Zhang G; Cao X
    Cardiovasc Drugs Ther; 2023 Feb; 37(1):199-216. PubMed ID: 34319489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Reticulated Platelets on the Antiplatelet Effect of the Intravenous P2Y12-Receptor Inhibitor Cangrelor.
    Stratz C; Nührenberg T; Valina CM; Löffelhardt N; Mashayekhi K; Ferenc M; Trenk D; Neumann FJ; Hochholzer W
    Thromb Haemost; 2018 Feb; 118(2):362-368. PubMed ID: 29443372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers.
    Bhatt DL; Pollack CV; Weitz JI; Jennings LK; Xu S; Arnold SE; Umstead BR; Mays MC; Lee JS
    N Engl J Med; 2019 May; 380(19):1825-1833. PubMed ID: 30883047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The platelet P2Y₁₂ receptor for adenosine diphosphate: congenital and drug-induced defects.
    Cattaneo M
    Blood; 2011 Feb; 117(7):2102-12. PubMed ID: 20966167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.